TC
TECH icon

TradeLink Capital’s Bio-Techne TECH Stock Holding History

TradeLink Capital’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.74M Sell
20,613
-191
-0.9% -$11.5K 13.12% 1
2025
Q4 		$1.22M Buy
+20,804
New +$1.26M 9.78% 2

Other funds holding TECH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

TradeLink Capital's TECH Position: Q1 2026 in Review

TradeLink Capital reduced its Bio-Techne (TECH) stake by 0.92% in Q1 2026, selling an estimated $11.5K and leaving 20,613 shares worth $1.74M. The position accounts for 13.12% of the portfolio, ranked #1.

TradeLink Capital first reported a position in TECH in Q4 2025 and has held it in 2 quarters since. 582 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

  • TradeLink Capital held 20,613 shares of Bio-Techne worth $1.74M as of Q1 2026.
  • TradeLink Capital sold 191 Bio-Techne shares in Q1 2026, an estimated $11.5K.
  • Bio-Techne made up 13.12% of TradeLink Capital's portfolio in Q1 2026, its #1 holding.
  • TradeLink Capital first reported a position in Bio-Techne in Q4 2025 and has held it in 2 quarters since.
  • 582 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on TradeLink Capital's 13F filing for Q1 2026, filed 13 May 2026.